Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners

Latham & Watkins represented Spectrum Pharmaceuticals in the deal.Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into a…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now